Ornopia, Roy L.
HRN: 11-59-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/14/2023
08/20/2023
IV
4.5
Q8
Sepsis/pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes